If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini......
Union health ministry officials on Thursday clarified that the intent of the Indian Council of Medical Research director general's letter envisaging the launch of COVID-19 vaccine by August 15 was......
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and......
An estimated one crore frontline health workers will received the first dose of COVID-19 vaccine whenever it becomes available, with around 92 per cent of government hospitals and 55 per cent of......
Three COVID-19 vaccines, developed by Bharat Biotech, Serum Institute of India and Pfizer, are under active consideration of India's drug regulator and there is hope that early licensure is......
Cadila Healthcare Ltd board approved amalgamation of German Remedies Ltd, Recon Healthcare Ltd, Zydus Pathline Ltd & Zoom Properties Ltd with the company.The boards of Cadila Health Care and German......
Cadila Healthcare Ltd has informed BSE that pursuant to Order dated January 31, 2003 passed by Hon'ble High Court of Gujarat in the matter of approval of Scheme of Amalgamation of German Remedies......
A meeting of the board of Cadila Healthcare Ltd will be held on January 29 to consider the quarterly results for the third quarter ended December 31, 2002.BSE Code:...
The Board of Directors of German Remedies Ltd at their meeting held on January 15, 2003 decided in principle under Section 391/394 and other applicable provisions of the Companies Act 1956 for the......
Cadila Healthcare Ltd has posted a net profit of Rs 172.91 million for the quarter ended December 31, 2002 as compared to Rs 147.03 million for the quarter ended December 31, 2001. Total income has......